跳至主要内容
临床试验/CTRI/2024/05/067985
CTRI/2024/05/067985已完成4 期

Anti hypertensive Efficacy Of Combination Therapy Of Sarpagandha Vati With Anuloman Chikitsa(Haritaki Churna) On Vyana Bala Vaishamya(Hypertension) randomised clinical trial

Ch Brahm Prakash Ayurved Charak Sansthan1 个研究点 分布在 1 个国家目标入组 90 人开始时间: 2024年6月27日最近更新:

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
90
试验地点
1
主要终点
Improvement in symptoms of Vyana Bala Vaishamya(Hypertension).

研究概览

简要总结

Vyana Bala Vaishamya cab be defined as imbalance in activities of Vyana Vata which leads to increase in force in the walls of blood vessels.

Blood pressure is defined as lateral pressure of column of blood  on the wall of blood vessels while flowing through it. Blood pressure affected by two factors i e peripheral resistance and cardiac output.

Criteria for normal blood pressure , prehypertension and hypertension (stage1 and stage2) have been recently revised by AHA/ACC( American college of cardiology and American heart association).

According to criteria -

normal cut-off values for systolic and diastolic blood pressure are taken <120 and <80mmhg respectively.

Arterial blood pressure is considered elevated at SBP of 120-129 and DBP <80mmhg.

Stage1 hypertension is SBP 130-139mmhg or DBP of 80-89mmhg.

Stage2 hypertension is labelled in case with corresponding values of SBP as >=140mmhg and DBP >=90mmhg.

Sarpagandha vati abd haritaki churna is effective to reduce blood pressure and symptoms of vyana bala vaishamya.

The present study is aimed to to find efficacy of sarpagandha vati with anuloman chikitsa on vyana bala vaishamya.

The study type is interventional and study design is randomized clinical trial with sample size of 90

研究设计

研究类型
Interventional
分配方式
Randomized
盲法
None

入排标准

年龄范围
18.00 Year(s) 至 50.00 Year(s)(—)
性别
All

入选标准

  • Patient of either sex with age between 18-50 years.
  • Newly diagnosed stage1 primary hypertensive patients( not on medication).

排除标准

  • Primary hypertension other than stage1 eg.
  • stage2, Benign hypertension, malignant hypertension, isolated hypertension.
  • Secondary hypertension.
  • Stage1, primary hypertension with co morbidities.
  • Stage1 hypertensive patient on regular medication.
  • Pregnant woman and lactating mother.
  • Gestational hypertension.

结局指标

主要结局

Improvement in symptoms of Vyana Bala Vaishamya(Hypertension).

时间窗: 12 Months

Reduction in blood pressure readings.

时间窗: 12 Months

次要结局

  • The study will provide cost effective(safe drug with lesser side effects.)

研究者

发起方
Ch Brahm Prakash Ayurved Charak Sansthan
申办方类型
Government medical college
责任方
Principal Investigator
主要研究者

Dr Jaynarayan Sharma

Ch Brahm Prakash Ayurved Charak Sansthan ,Khera Dabar Najafgah South West Delhi 110073

研究点 (1)

Loading locations...

相似试验